Joshua Patterson's most recent trade in Cg Oncology Inc. was a trade of 119,922 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cg Oncology Inc. | Joshua Patterson F. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 119,922 | 119,922 | - | - | Employee Stock Option (Right to Buy) | |
| Gamida Cell | Joshua Patterson | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 480,319 | 855,461 | - | 0 | Ordinary Shares | |
| Gamida Cell | Joshua Patterson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 125,860 | 125,860 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell | Joshua Patterson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 63,000 | 144,000 | - | 0 | Ordinary Shares | |
| Gamida Cell | Joshua Patterson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 77,900 | 77,900 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell | Joshua Patterson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 51,000 | 81,000 | - | 0 | Ordinary Shares |